The immunohistochemical analysis of COL1A2, COL3A1, and COL21A1 revealed that regardless of the type of analyzed ovarian cancer subtype the expression of those proteins was present not only in the ECM surrounding the tumor (what was expected) but also in cancer cells. This evidence concerns the gene COL3A1 and ovarian carcinoma.